Intermittent chemotherapy is a treatment choice for advanced urothelial cancer.

Abstract:

OBJECTIVE:To investigate the potential benefit of intermittent chemotherapy, and to identify the eligibility criteria offering intermittent chemotherapy to patients with advanced urothelial cancer. MATERIALS AND METHODS:Twenty patients who responded or had stable disease after receiving 3 cycles of induction chemotherapy (gemcitabine and cisplatin, or paclitaxel and carboplatin) were enrolled for a prospective study of intermittent chemotherapy. We evaluated for the duration of chemotherapy holiday, toxicity, quality of life (QOL), and overall survival. RESULTS:The median number of cycles was 7 (range, 3-25). On resumption of treatment after the first chemotherapy holiday, 65% of the patients had partial response, 25% had stable disease, and 10% of the patients developed disease progression. The median duration of chemotherapy holiday was 22 weeks (range, 4-94), and the median chemotherapy holiday rate (CHR) was 0.53 (range, 0.25-0.86). The duration of the first chemotherapy holiday of more than 8 weeks significantly correlated to a high CHR. A response to induction chemotherapy, and normal levels of albumin and hemoglobin significantly correlated with a higher CHR. A significant improvement in fatigue, nausea and vomiting, and appetite loss was seen in the symptom scales of QLQ-C30 during the chemotherapy holiday. CONCLUSIONS:Intermittent chemotherapy is a feasible treatment strategy to balance disease control and QOL in selected patients.

journal_name

Oncology

journal_title

Oncology

authors

Onishi T,Sasaki T,Hoshina A

doi

10.1159/000338770

subject

Has Abstract

pub_date

2012-01-01 00:00:00

pages

50-6

issue

1

eissn

0030-2414

issn

1423-0232

pii

000338770

journal_volume

83

pub_type

临床试验,杂志文章

相关文献

ONCOLOGY文献大全
  • Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.

    abstract:INTRODUCTION:Because the frequency of bile duct invasion in hepatocellular carcinoma (HCC) patients is very rare, there is limited clinical evidence to demonstrate the outcomes of systemic therapy in HCC with bile duct invasion. OBJECTIVE:Our aim was to clarify the efficacy and safety of sorafenib treatment in patient...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000507051

    authors: Tanaka T,Kuzuya T,Ishigami M,Ito T,Ishizu Y,Honda T,Ishikawa T,Fujishiro M

    更新日期:2020-01-01 00:00:00

  • Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.

    abstract::203 tumor specimens from 175 patients were studied. Amplification of ERBB-2 was detected in 14 out of 63 (22%) cases of breast carcinoma, in 1 out of 23 patients with ovarian cancers, in 1 out of 19 cases of colon carcinoma and in 1 out of 27 patients with thyroid cancer. We failed to find more than one copy of ERBB-2...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227032

    authors: Knyazev PG,Imyanitov EN,Chernitca OI,Nikiforova IF,Hanson KP

    更新日期:1992-01-01 00:00:00

  • Characterization of physical binding between human papillomavirus 18 protein E7 and centromere protein C.

    abstract::Human papillomaviruses (HPVs) have been linked to a variety of human diseases, most notably cancer of the cervix. In the majority of cases, HPV proteins E6 and E7 are continuously expressed and bind a variety of cellular proteins. The precise mechanism of HPV-induced carcinogenesis has not been fully elucidated; there...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000322188

    authors: Yaginuma Y,Yoda K,Ogawa K

    更新日期:2010-01-01 00:00:00

  • Flow cytometric analysis of the DNA content of tumor cells in cases of gastric cancer in the upper third of the stomach and in the remnant stomach.

    abstract::Thirteen samples of gastric tumors that had developed in the remnant stomach (remnant gastric cancer) were compared with 63 samples of primary gastric tumors located in the upper third of the stomach (primary gastric cancer) by both clinicopathologic and flow cytometric analysis. The depths of invasion of all these tu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227441

    authors: Ikeguchi M,Kondou A,Oka A,Tsujitani S,Maeta M,Kaibara N

    更新日期:1995-03-01 00:00:00

  • Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.

    abstract:BACKGROUND:The present study sought to evaluate an inflammation-based prognostic score (Glasgow prognostic score, GPS) and the neutrophil to lymphocyte ratio (NLR) as prognostic factors in patients receiving chemotherapy for advanced gastric cancer. METHODS:The study enrolled 224 patients who received chemotherapy for...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000446373

    authors: Namikawa T,Munekage E,Munekage M,Maeda H,Yatabe T,Kitagawa H,Kobayashi M,Hanazaki K

    更新日期:2016-01-01 00:00:00

  • Characterization of suppressor cells in mice with a transplantable malignant melanoma.

    abstract::C57BL/6 mice with progressive B-16 melanoma develop a generalized immunosuppression, as measured by their lack of response to SRBC in vivo and in vitro. The severity of immunosuppression increases with the progress of the tumor, and is due to the generation of an antigen-nonspecific suppressor cell. Suppressor cells w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225480

    authors: Stelzer GT,Wallace JH

    更新日期:1980-01-01 00:00:00

  • Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.

    abstract:PURPOSE:There is no standard second-line therapy for patients with oesophagogastric cancer who progress following first-line chemotherapy for advanced disease or relapse following radical multi-modality therapy. The aim of this retrospective study was to evaluate survival following rechallenge with platinum plus fluoro...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000322114

    authors: Okines AF,Asghar U,Cunningham D,Ashley S,Ashton J,Jackson K,Hawkes E,Chau I

    更新日期:2010-01-01 00:00:00

  • Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer.

    abstract::The association of MMP-2 (matrix metalloproteinase 2, 72-kD collagenase IV) with invasive and metastatic capacity of tumor cells has implicated a potential role in the prognosis for cancer patients. However, no larger study has been done to prove this hypothesis. The present study was therefore designed to investigate...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011850

    authors: Allgayer H,Babic R,Beyer BC,Grützner KU,Tarabichi A,Schildberg FW,Heiss MM

    更新日期:1998-03-01 00:00:00

  • Endometrial cancer and the IGF system: a case-control study in Greece.

    abstract:OBJECTIVES:Insulin-like growth factor I (IGF-I) and other components of the IGF system have been implicated in the etiology of several human malignancies. We have undertaken a case-control study among Greek women to explore the relation of major components of the IGF system (IGF-I, IGF-II and IGF-binding protein 3, IGF...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000070291

    authors: Petridou E,Koukoulomatis P,Alexe DM,Voulgaris Z,Spanos E,Trichopoulos D

    更新日期:2003-01-01 00:00:00

  • Value of serum neuron-specific enolase in nonsmall cell lung cancer.

    abstract::To assess the prognostic value of pretreatment serum neuron-specific enolase (NSE) in nonsmall cell lung cancer (NSCLC), levels were measured in 84 NSCLC patients, 40 healthy controls, and 20 patients with benign pulmonary diseases. NSE concentration was higher in NSCLC (11.7 +/- 10.8 ng/ml) (mean +/- SD; median = 9.7...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227163

    authors: Diez M,Torres A,Ortega L,Maestro M,Hernando F,Gomez A,Picardo A,Granell J,Balibrea JL

    更新日期:1993-03-01 00:00:00

  • Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico.

    abstract:BACKGROUND:Variations in the incidence of cancer can be influenced by diet and specific lifestyles. In the last years, diet has been evaluated as an important factor in the development of ovarian cancer, even though the results have not been consistent. Dietary factors related to the risk of ovarian cancer in Mexican w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000063814

    authors: Salazar-Martinez E,Lazcano-Ponce EC,Gonzalez Lira-Lira G,Escudero-De los Rios P,Hernandez-Avila M

    更新日期:2002-01-01 00:00:00

  • Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.

    abstract:BACKGROUND:Identification of high-risk stage II colorectal cancer (CRC) patients, potential candidates for adjuvant chemotherapy, is challenging. Current clinical guidelines rely mainly on histopathological markers with relatively weak prognostic value. This motivates further search for prognostic markers. METHODS:Thi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000507118

    authors: Dimberg J,Andersson RE,Haglund S

    更新日期:2020-01-01 00:00:00

  • Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.

    abstract::A number of therapeutic agents including L-asparaginase, Actinomycin-D, CCNU, Hydroxyurea, 5-FU, Cis-platinum, Cyclophosphamide, orchiectomy, Adriamycin and DES alone and in various combinations has been applied against the Dunning R-3327 rat prostatic adenocarcinoma subline G. We have found a parallel between the res...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225202

    authors: Block NL,Camuzzi F,Denefrio J,Troner M,Claflin A,Stover B,Politano VA

    更新日期:1977-01-01 00:00:00

  • Platelet-mimicry of cancer cells: epiphenomenon with clinical significance.

    abstract::Stem cell mimicry of cancer cells has been known for a long time and is considered to be responsible for ectopic gene expressions. The stem cell characteristics of tumor cells are shown to be involved in epithelial-mesenchymal transition and in the phenomenon of vascular mimicry. Certain cancer types acquire a geno-ph...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000088069

    authors: Tímár J,Tóvári J,Rásó E,Mészáros L,Bereczky B,Lapis K

    更新日期:2005-01-01 00:00:00

  • Transforming activity of DNA extracted from BKV-transformed hamster cells after passages in culture.

    abstract::Primary fetal rat fibroblasts (FRF cells) were transfected with DNA extracted from BKV-transformed hamster kidney cells at low passage after transformation (HKBKlp cells) and at high passage after transformation (HKBKhp cells). Two transformed rat cell lines were obtained, FRF-DNA-HKBKlp cells and FRF-DNA-HKBKhp cells...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226404

    authors: Possati L,Collesi A,Rosciani C,Rubini C

    更新日期:1986-01-01 00:00:00

  • Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer.

    abstract::Cyclin D3 promotes cell cycle progression but its expression and prognostic significance in human colorectal cancer is unknown. This study assayed cyclin D3 expression against cell cycle phase fraction and Duke's stage in 35 fresh human primary colorectal cancers. DNA content, cell cycle phase fraction and cyclin D3 e...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011932

    authors: Watson DS,Brotherick I,Shenton BK,Wilson RG,Angus B,Varma JS,Campbell FC

    更新日期:1999-01-01 00:00:00

  • Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status.

    abstract:OBJECTIVES AND METHODS:The association oxaliplatin (OXA)-5-fluorouracil/folinic acid (FUFA) is currently a standard first-line treatment for advanced colorectal cancer. The main objective of this experimental study was to examine the cytotoxic effects resulting from the addition of ionizing radiation (Rgamma) to the co...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000069308

    authors: Magné N,Fischel JL,Formento P,Etienne MC,Dubreuil A,Marcié S,Lagrange JL,Milano G

    更新日期:2003-01-01 00:00:00

  • Biological effects of 5-azacytidine in eukaryotes.

    abstract::5-Azacytidine (NSC-102 816) was prepared synthetically and independently isolated from the culture filtrate of Streptoverticillium ladakanus. It is an s-triazine analogue of cytidine possessing a broad spectrum of biological effects. In mammalian tissueit is phosphorylated to 5-azacytidine 5-phosphates and incorporate...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000224981

    authors: Cihák A

    更新日期:1974-01-01 00:00:00

  • Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial).

    abstract::We conducted a prospective multicenter phase II trial of patients with borderline resectable pancreatic carcinoma to investigate the efficacy of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival (OS). The clinical trial primarily evaluated OS time from the first day of protocol therapy as a prima...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000478660

    authors: Okada KI,Shimokawa T,Hirono S,Kawai M,Sho M,Satoi S,Matsumoto I,Eguchi H,Murakami Y,Yamada S,Doi M,Yamaue H,NAC-GA investigators.

    更新日期:2017-01-01 00:00:00

  • Models, mechanisms and management of anticipatory nausea and emesis.

    abstract::Anticipatory nausea and vomiting (ANV) are learned responses to chemotherapy that develop in up to 25% of patients by the fourth treatment cycle. Post-treatment nausea and emesis must occur before development of ANV can take place. Certain patient characteristics and other responses to chemotherapy can also be used to...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227633

    authors: Morrow GR,Rosenthal SN

    更新日期:1996-06-01 00:00:00

  • Cisplatin, vindesine, pepleomycin and concurrent radiation therapy following esophagectomy with lymph adenectomy for patients with an esophageal carcinoma.

    abstract::Between 1986 and 1991, 35 patients with esophageal cancer (TNM stages II-IV) underwent transthoracic esophagectomy with lymph adenectomy and were subsequently treated with 5,000 cGy of radiation (days 1-40) and concurrently with two courses of chemotherapy (cisplatin, vindesine and pepleomycin, days 21-26 and 49-54). ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227198

    authors: Saito T,Shigemitsu Y,Kinoshita T,Shimoda K,Abe T,Nakamura A,Chikuba K,Kobayashi M

    更新日期:1993-07-01 00:00:00

  • Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.

    abstract::A multidrug-resistant (MDR) cell line isolated from HOB1 lymphoma cells was characterized. The MDR phenotype in this cell line was typified by resistance to vincristine with varying degrees of cross-resistance to Adriamycin, colcemid and actinomycin D. Decreased intracellular [3H]vincristine with concurrent increase i...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227300

    authors: Lee WP,Lee CL

    更新日期:1994-01-01 00:00:00

  • Low-dose aminoglutethimide therapy without glucocorticoid administration. Clinical and hormonal findings.

    abstract::Eleven postmenopausal patients with advanced breast cancer were assessed for their response and endocrine changes to low-dose aminoglutethimide (250 mg twice a day) therapy without steroid administration. In 7 cases an objective response was registered; 1 patient had a stabilization of the disease lasting for 9 months...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227006

    authors: Kahán Z,Tóth I,Vecsernyés M

    更新日期:1992-01-01 00:00:00

  • Differences in cellular proteins between high and low metastatic potential sublines from the methylcholanthrene-induced rat fibrosarcoma cell line.

    abstract::The purpose of the present study was to determine with two-dimensional electrophoresis whether two sublines (high and low metastatic potential to lymph nodes) of rat fibrosarcoma induced by methylcholanthrene have differences in cellular proteins. The high metastatic potential subline had a specific protein in the pro...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227028

    authors: Minato K,Manabe T,Okuyama N,Sasaki Y,Nakagawa K,Saijo N

    更新日期:1992-01-01 00:00:00

  • Clonal composition of malignant fibrous histiocytoma: analysis by PCR-based assay of the human androgen receptor gene (HUMARA).

    abstract::Malignant fibrous histiocytoma (MFH), the most common soft-tissue sarcoma, consists mainly of two different cell populations: histiocytelike and fibroblastlike cells. It has been suggested to contain a large amount of reactive histiocytes and fibroblasts hard to distinguish from the tumor cells. In this study, the clo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011919

    authors: Fujita MQ,Hashida N,Shin M,Nakanishi H,Yoshihara W,Aozasa K

    更新日期:1998-11-01 00:00:00

  • Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.

    abstract:OBJECTIVES:Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in China and, due to the limited efficacy of currently available therapies, is responsible for a large number of deaths. IFN-alpha therapy has shown promise in the treatment of various forms of human cancer and is considered in the trea...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000082928

    authors: Wu WZ,Sun HC,Gao YQ,Li Y,Wang L,Zhou K,Liu KD,Iliakis G,Tang ZY

    更新日期:2004-01-01 00:00:00

  • Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments.

    abstract:OBJECTIVE:New effective therapy is desirable for patients with non-small cell lung cancer (NSCLC) who have failed previous treatments. Fractionated administration of paclitaxel may be less toxic and more active against NSCLC. The aim of this study was to evaluate the activity and toxicity of weekly paclitaxel therapy f...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000079481

    authors: Yasuda K,Igishi T,Kawasaki Y,Kato K,Matsumoto S,Katayama S,Sako T,Shigeoka Y,Suyama H,Sugitani A,Yamamoto M,Hitsuda Y,Shimizu E

    更新日期:2004-01-01 00:00:00

  • Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.

    abstract:BACKGROUND:Cisplatin-pemetrexed combination chemotherapy is the current standard primary treatment for malignant pleural mesothelioma (MPM). It was first approved for untreated and unresectable MPM in the 2003 National Comprehensive Cancer Network (NCCN) guidelines. However, to date, standard treatments for patients wi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000510691

    authors: Koda Y,Kuribayashi K,Doi H,Kitajima K,Nakajima Y,Ishigaki H,Nakamura A,Minami T,Takahashi R,Yokoi T,Kijima T

    更新日期:2020-10-14 00:00:00

  • Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.

    abstract:OBJECTIVES:Primary chemoradiotherapy for locally advanced pancreatic cancer (LAPC) may improve local control, curative resection rate and long-term survival. We performed a phase II study to evaluate toxicity and activity of primary radiation therapy and concurrent chemotherapy with gemcitabine (GEM) twice weekly in pa...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000086993

    authors: Magnino A,Gatti M,Massucco P,Sperti E,Faggiuolo R,Regge D,Capussotti L,Gabriele P,Aglietta M

    更新日期:2005-01-01 00:00:00

  • Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.

    abstract::Capecitabine is converted to 5-fluorouracil by thymidine phosphorylase, and mitomycin C is capable of upregulating the expression of thymidine phosphorylase suggesting a synergistic effect. Fifty-three patients (median age 62 years) with anthracycline- and taxane-resistant, metastatic breast cancer received mitomycin ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000096250

    authors: Massacesi C,La Cesa A,Marcucci F,Pilone A,Rocchi MB,Zepponi L,Santini D,Tonini G,Burattini L

    更新日期:2006-01-01 00:00:00